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Abstract 
 
An isocratic reversed phase high performance liquid chromatographic method with DAD detection was 
developed for the analysis of metronidazole, oxytetracycline and furazolidone. The mobile phase 
consisted of pH 2.5 phosphate buffer solution, methanol and acetonitrile (70:18:12). The UV detection 
was carried out at 264 nm, and the flow rate was 1.100 mL/min. The separation was carried out on a 
Nucleosil C18 column, 5 µm 250 mmx4.6 mm, which was maintained at 25 
0C. This method was validated 
by system suitability parameters, linearity, limits of detection and quantification, precision and accuracy  
 
Rezumat 
 
Determinarea metronidazolului, oxitetraciclinei si furazolidnei s-a facut printr-o metoda de cromatografie 
de lichid de inalta performanta, prin elutie izocratica. Faza mobila a fost formata din fosfat de potasiu 
monobazic 50 mM cu pH 2.5, metanol si acetonitril (70:18:12). Detectia s-a facut la lungimea de unda de 
264 nm, folosind un debit de 1.100 mL/min. Separarea s-a realizat pe o coloana Nucleosil C18 column, 5 
µm 250 mmx4.6 mm, mentinuta la temperatura de 25 
0C. Metoda a fost validata urmarind parametrii: 
system suitability, liniaritate, limita de detectie si de cuantificare, precizie si acuratete. 
 
Introduction 
 
Oxytetracycline is a broad spectrum 
antibiotic cu used in the veterinary medicine 
to inhibit gram-positive and gram-negative 
bacteria synthesis. 
The European Committee has approved 
the use of oxytetracycline in a wide range of 
species: cats, dogs, sheep, goats and swine. 
Both oxytetracycline and oxytetracycline 
hydrochloride contain impurities that in the 
starting material should not exceed the 
European Pharmacopeia-required limits. 
Furazolidone is a nitrofuran antibacterial 
with a nitro group in its molecular structure.  
This group has a broad antibacterial and 
antiparasitic action and this is why 
nitrofurans are widely used in the treatment 
of gastrointestinal infections in cage birds, 
dogs and cats.  
Metronidazole  is  effective  against 
protozoa and anaerobic bacteria, being used 
for prevention and treatment as well. 
The proposed method is simple, precise, 
specific and, above all, appropriate for the 
determination  of  metronidazole, 
oxytetracycline  and  furazolidone  in 
Enterogurd M- powder. 
 
1. Materials and method 
 
1.1. Reference materials and reagents 
 
x The  metronidazole  standard  was 
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x The  oxytetracycline  standard  was 
purchased  from  the  European 
Pharmacopeia.  
x The  furazolidone  standard  was 
purchased from the USP 
x The studied pharmaceutical product, 
Enteroguard M – tablets was supplied 
by Romvac Company.  
x Ultrapure water was used for the 
preparation of all solutions, obtained 
in-house with  a  Milli-Q system 
(MILLIPORE, USA).  
x The HPLC methanol and acetonitrile 
were supplied by Merck. The HPLC 
monobasic potassium phosphate and 
hydrochloric acid were supplied by 
Fluka. The 85% orthophosphoric acid, 
used  for  pH  adjustment,  was 
purchased from Merck.  
x Dimethylformamide (DMF) used for 
sample preparation was purchased 
from Sigma. 
 
1.2. Chromatographic system and 
conditions 
 
The  chromatographic system used, LC 
Surveyor (Thermo Electron Corporation, 
USA) is provided with quaternary pump, 
autosampler, 25 µL loop, column thermostat, 
autosampler thermostat and UV-VIS – diode 
array detector. The entire chromatographic 
system is controlled with ChromQuest soft. 
The  chromatographic separation  was 
done on a Nucleosil C18, 5 µm, 250 mm x 
4.6 mm column. The mobile phase contains: 
50 mM monobasic potassium phosphate 
with  pH 2.5, methanol and acetonitrile 
(70:18:12). The 1.1 mL/min flow rate, 254 
nm wavelength and 10 µL injection volume 
are parameters set for this method.  
 
1.3. Preparation of standard stock 
solutions 
 
The  standard metronidazole  solution 
was prepared dissolving 10 mg of standard 
in 10 mL methanol.  
The standard furazolidone solution was 
prepared dissolving 10 mg of standard in 10 
mL DMF.  
The  standard stock oxytetracycline 
hydrochloride  solution  was  prepared 
dissolving 10 mg of standard in 10 mL HCl 
0.01 M. 
 
1.4 Sample preparation 
 
In a volumetric flask (de 50 mL) was 
weighed 0.254 g of Enteroguard M -powder, 
(equal to 25 mg metronidazole, 15 mg 
oxytetracycline and 5 mg furazolidone). 5 mL 
HCl 0.1M, 8 mL DMF and 15 mL water were 
poured over this amount and the solution 
obtained was sonicated for 10 minutes. 
 
1.5. Validation of the chromatographic 
method 
 
This method was validated studying 
various parameters: specificity, linearity, limit 
of detection and quantification, precision and 
accuracy. 
Specificity  was  checked  calculating 
parameters  such  as:  retention  time, 
theoretical plates, asymmetry, resolution and 
capacity factor. 
To determine calibration curves linearity, 
five concentrations within 10% - 200% were 
prepared  from  stock  solutions  of 
metronidazole,  oxytetracycline  and 
furazolidone.  
The calibration curves were used for the 
determination of limits of detection and 
quantification.  
Method precision was determined by 
injecting  six  individual  samples  of 
Enteroguard M- powder. 
Method accuracy can be assessed by 
the recovery percents of metronidazole, 
oxytetracycline and furazolidone.  
The recovery study was conducted 
using sample solutions with concentrations 
within 80%-120%. 
 
 Tauber & Chiurciu                                                                                                                Medicamentul Veterinar / Veterinary Drug 
 
                                                                                                                                                             Vol. 8 (1). Mai - Iunie 2014 
 
82 
2. Results and discussions 
 
The objective of this study was to 
develop a HPLC method allowing separation 
of  metronidazole,  oxytetracycline  and 
furazolidone.  
A common chromatogram of a sample of 
Enterogurd M-powder is described in Figure 
1. The active substances were prepared with 
good asymmetry in eight minutes. The 
retention times were 2.5, 4.1 and 
respectively  5.3  for  metronidazole, 
oxytetracycline and furazolidone.  
The identification of active substances 
was confirmed using a soft calculating other 
performance parameters as well, such as 
resolution, asymmetry, retention time and 
theoretical plates, table 2. 
The statistical assessment of results for 
active substances in Enteroguard M –
powder is shown in table 3. 
 
 
 
Fig.1. Common chromatogram of Enteroguard M - powder 
Table 1 
Parameters calculated for the mixture in Figure 1 
 
Name  Retention 
Time  Area  Resolution  Asymmetry  Capacity 
factor 
Theoretical 
plates 
Metronidazole  2.593  2519440  0.00000  1.01999  2  6726 
Oxytetracycline 
hydrochloride  4.155  2692618  8.67410  0.97944  3  5021 
Furazolidone  5.300  1422186  4.96785  0.90892  4  8673 
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Table 2 
Validated method results 
 
Validation parameters  Metronidazole  Oxytetracycline  Furazolidone 
LOD mg/mL  0.000358  0.000130  0.001109 
LOQ mg/mL  0.001194  0.000432  0.003696 
Regression equation 
y=2.26968e-008x– 
0.00134127 
y=1.21776e-008x– 
4.94260e-006 
y=7.58344e-008x– 
4.94260e-006 
Correlation coefficient (r2)  0,998711  0.999608  0.999608 
Linearity domain mg/mL  0.005-0.1  0.003-0.06  0.001-0.02 
Repeatability %RSD n=6  0. 356  0.301  0.333 
Reproducibility %RSD  0.525  0.383  0.500 
% recovery  100.7  97.49  89.72 
 
 
Conclusions 
 
In this study, the analytical parameters 
for the threeactive substances were 
optimized using high performance liquid 
chromatography.  
Separation was isocratic with a mobile 
phase consisting of 50 mM monobasic 
potassium phosphate with pH 2.5, 
methanol and acetonitrile (70:18: 12) and 
a flow rate of 1.100 mL/min.  
The chromatographic analysis time 
was short (8 min) and peak resolution 
was good for all active substances. 
In conclusion, this study demonstrates 
that the analytical method applies is 
sensitive, selective and fast for the 
determination  of  metronidazole, 
oxytetracycline  and  furazolidone  in 
Enteroguard M–powder. 
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